SUZHOU, China, July 22, 2023 /PRNewswire/ — Last month, the American Society for Artificial Internal Organs (ASAIO) 68th Annual Meeting was successfully held in San Francisco. magAssist’s product, BreathMo® was highlighted in the meeting. Dr. Dong Guo from Beijing Anzhen Hospital, introduced the innovation of the device featured in a study titled “A 14-Day In-Vivo Evaluation of a … Read more
With uMI Panorama™, United Imaging Continues to Push the Envelope on Whole-Body System Performance HOUSTON, June 25, 2023 /PRNewswire/ — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and a Leadership Circle sponsor at this year’s SNMMI, is making news on several fronts at SNMMI’s annual meeting in Chicago this … Read more
KYOTO, Japan, June 23, 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) of Kyoto, Japan, has announced the official sponsorship of the 32nd Scientific Meeting of the European Society of Hypertension (hereinafter referred to as ESH 2023) via OMRON Healthcare Europe B.V., OMRON Healthcare’s sales and marketing headquarters in Europe. … Read more
TOKYO, June 22, 2023 /PRNewswire/ — The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end … Read more
TOKYO, June 22, 2023 /PRNewswire/ — The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end … Read more
Mice with a conditional deletion of the Tsc2 gene in CD11c+ cells leading to chronic activation of mTORC1 signaling in myeloid cells, caused spontaneous cardiac sarcoid-like granulomas. Inhibiting MMP-12 with FP-020 attenuated macrophage infiltration, macrophage clustering, decreased fibrotic replacement, and reduced the number of activated fibroblasts. MMP-12 might therefore be required for granuloma formation and persistence, and further … Read more
Mice with a conditional deletion of the Tsc2 gene in CD11c+ cells leading to chronic activation of mTORC1 signaling in myeloid cells, caused spontaneous cardiac sarcoid-like granulomas. Inhibiting MMP-12 with FP-020 attenuated macrophage infiltration, macrophage clustering, decreased fibrotic replacement, and reduced the number of activated fibroblasts. MMP-12 might therefore be required for granuloma formation and persistence, and further … Read more
NANCHANG, Chine, 20 juin 2023 /PRNewswire/ — Le 20e salon China Association of Clinical Laboratory Practice Expo (CACLP) et le 3e salon China IVD Supply Chain Expo (CISCE), reconnus comme les leaders mondiaux en matière d’exposition de diagnostics in vitro, qui ont eu lieu du 28 au 30 mai 2023 à Nanchang, en Chine, ont connu un succès remarquable. … Read more
HEFEI, Chine, 19 juin 2023 /PRNewswire/ — TG ImmunoPharma Co. (TGI), une société de biotechnologie de premier plan spécialisée dans le développement de nouvelles thérapies immuno-oncologiques, a le plaisir d’annoncer que la FDA a autorisé l’essai clinique du TGI-6, son anticorps bispécifique révolutionnaire. Le TGI-6 cible simultanément les antigènes associés aux tumeurs (TAA) et les molécules CD3, … Read more
HEFEI, China, 19 juni 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), een toonaangevend biotechbedrijf dat focust op de ontwikkeling van nieuwe immuno-oncologische therapieën, is verheugd aan te kondigen dat de FDA goedkeuring heeft gegeven voor het klinische onderzoek naar TGI-6, zijn baanbrekend bispecifiek antilichaam. TGI-6 mikt tegelijkertijd op unieke tumor-geassocieerde antigenen (TAA) en CD3-moleculen, … Read more